Shipping & Air Freight
In the face of various packaging modes, Pharma Logistics IQ explores the advantages and drawbacks that should be considered when making decisions on the application of reusable or disposable packaging solutions within the cold chain.
Maritime Executive - CASE STUDY: Why AstraZeneca are on Course to Achieve 70% Sea Volume Ratio by 2018
At TCL 2018, Julian Wann, Global Category Lead, Freight and Logistics and Andrew Spencer, Global Category Manager, Freight and Logistics from AstraZeneca presented this case study on "Why AstraZeneca are on Course to Achieve 70% Sea Volume Ratio by 2018".
Download this presentation to:
- Discover how utilising sea freight can better ensure that: product quality is maintained, temperature excursions are reduced, transportation is more sustainable, and supply chain cost are lower
- Examine the strategies that that AstraZeneca have employed in their significant modal shift
- Benchmark your own sea freight strategy with other pharma manufactures